Biophytis Announces The Design Of Its Phase 2 OBA Clinical Study In Obesity With BIO101 (20-hydroxyecdysone)

BIO101 (20-hydroxyecdysone) will be evaluated in obese patients treated with GLP-1 RAs, together with hypocaloric dieting. The OBA phase 2 study will test the efficacy and safety of BIO101 (20-hydroxy

BenzingaMay 14 02:36

Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first

BenzingaApr 25 12:57

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading

European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,

MT NewswiresApr 25 10:06

Optinose OPTN Product Revenue; Biophytis BPTS NASDAQ Delist

BioPharmCatalystApr 25 07:26

Top Premarket Decliners

Biophytis (BPTS) shares slumped 15% Thursday premarket after the company said it will transfer its American Depositary Shares listing to the OTC Markets. Meta Platforms (META) shares retreated nearly

MT NewswiresApr 25 06:57

Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Shares of Teradyne, Inc. (NASDAQ:TER) rose sharply in today's pre-market trading after the company posted upbeat first-quarter results and issued strong second-quarter forecast.Teradyne posted adjuste

BenzingaApr 25 05:12